Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1903 1
1905 1
1909 1
1911 1
1918 1
1920 1
1928 1
1929 1
1934 1
1936 1
1937 2
1940 1
1942 1
1944 1
1945 4
1946 5
1947 18
1948 11
1949 8
1950 21
1951 42
1952 24
1953 36
1954 37
1955 48
1956 52
1957 55
1958 66
1959 61
1960 65
1961 53
1962 53
1963 179
1964 277
1965 187
1966 179
1967 182
1968 264
1969 296
1970 347
1971 450
1972 453
1973 559
1974 626
1975 680
1976 726
1977 707
1978 731
1979 762
1980 874
1981 890
1982 827
1983 911
1984 869
1985 900
1986 945
1987 876
1988 813
1989 908
1990 929
1991 987
1992 1024
1993 1016
1994 1092
1995 1077
1996 1135
1997 1169
1998 1275
1999 1360
2000 1435
2001 1449
2002 1498
2003 1767
2004 1760
2005 1845
2006 2024
2007 2026
2008 2015
2009 2082
2010 2193
2011 2261
2012 2418
2013 2445
2014 2486
2015 2512
2016 2418
2017 2301
2018 2365
2019 2472
2020 2746
2021 2766
2022 2452
2023 2264
2024 2185
2025 2374
2026 826

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79,562 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease.
Patrono C. Patrono C. Eur Heart J. 2024 Jul 12;45(27):2362-2376. doi: 10.1093/eurheartj/ehae324. Eur Heart J. 2024. PMID: 38839268 Free PMC article. Review.
During the past 30 years, several developments have occurred in the antiplatelet field, including the role of aspirin in primary prevention of atherosclerotic cardiovascular disease. There have been several attempts to develop antiplatelet drugs more effective and safer th …
During the past 30 years, several developments have occurred in the antiplatelet field, including the role of aspirin in primary prev …
Aspirin in Primary Prevention of Cardiovascular Events.
Soodi D, VanWormer JJ, Rezkalla SH. Soodi D, et al. Clin Med Res. 2020 Aug;18(2-3):89-94. doi: 10.3121/cmr.2020.1548. Epub 2020 Jun 24. Clin Med Res. 2020. PMID: 32580960 Free PMC article. Review.
Aspirin has demonstrated a clear benefit in secondary prevention of coronary syndrome, while aspirin's effect in primary prevention is unclear. ...A thoughtful discussion between patients and their doctors should be conducted before beginning aspirin u …
Aspirin has demonstrated a clear benefit in secondary prevention of coronary syndrome, while aspirin's effect in primar …
Aspirin in the Modern Era of Cardiovascular Disease Prevention.
Murphy E, Curneen JMG, McEvoy JW. Murphy E, et al. Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):36-47. doi: 10.14797/mdcvj.293. eCollection 2021. Methodist Debakey Cardiovasc J. 2021. PMID: 34824680 Free PMC article. Review.
Aspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its traditional use as a core therapy for secondary prevention of CVD is well recognized. However, with the advent of newer antiplatelet agents and …
Aspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its trad …
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. ...Nonetheless, …
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the effic …
Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: An analysis of the MIMIC-IV database.
Dong Y, Wei S, Liu Y, Ji X, Yin X, Wu Z, Wu S, Wang B, Wei S, Chen Y. Dong Y, et al. J Clin Anesth. 2024 Dec;99:111597. doi: 10.1016/j.jclinane.2024.111597. Epub 2024 Sep 7. J Clin Anesth. 2024. PMID: 39245010
BACKGROUND: The effectiveness of aspirin treatment in septic patients remains a subject of debates. OBJECTIVE: To explore the association between aspirin usage and the prognosis of patients with sepsis-induced myocardial injury (SIMI), as well as the timing of as …
BACKGROUND: The effectiveness of aspirin treatment in septic patients remains a subject of debates. OBJECTIVE: To explore the associa …
Aspirin nanosensors.
Koohkansaadi G, Tabean M, Mohagheghi A, Masoumi S, Jahanabad ZJ, Mobed A, Charsouei S. Koohkansaadi G, et al. Clin Chim Acta. 2025 Apr 15;571:120222. doi: 10.1016/j.cca.2025.120222. Epub 2025 Mar 7. Clin Chim Acta. 2025. PMID: 40058719 Review.
The accurate detection of aspirin in biological and environmental samples is essential for ensuring therapeutic efficacy and safety, particularly in patients at risk of stroke. ...This review synthesizes current research findings, explores the mechanisms underlying nanosen …
The accurate detection of aspirin in biological and environmental samples is essential for ensuring therapeutic efficacy and safety, …
Constructing a Preeclampsia Organoid Model to Elucidate the Mechanism of Aspirin.
Huang S, Zhang Y, Guo Y, Zhang Y, Huang J, Yang Y, Qi Q, Zhao L, Xu X, Shen Y, Liang C, Yao B, Wang X. Huang S, et al. Hypertension. 2025 Sep;82(9):e171-e185. doi: 10.1161/HYPERTENSIONAHA.125.25342. Epub 2025 Jul 16. Hypertension. 2025. PMID: 40665908
CONCLUSIONS: This study clarifies aspirin's multitarget mechanisms in alleviating preeclampsia, which include restoring the sFLT-1/PlGF balance, activating the PI3K-AKT-mTOR signaling pathway, optimizing mitochondrial function, and regulating CYP-mediated hormonal m …
CONCLUSIONS: This study clarifies aspirin's multitarget mechanisms in alleviating preeclampsia, which include restoring the sF …
Le syndrome de Widal en pratique clinique.
Borgeat Kaeser A, Ribi C. Borgeat Kaeser A, et al. Praxis (Bern 1994). 2017;106(22):1243-1249. doi: 10.1024/1661-8157/a002830. Praxis (Bern 1994). 2017. PMID: 29088964 Review. French. No abstract available.
Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease.
Chen Z, Chen M, Zeng P, Yang X, Li Q. Chen Z, et al. Scand J Gastroenterol. 2023 Jul-Dec;58(8):908-914. doi: 10.1080/00365521.2023.2179864. Epub 2023 Feb 17. Scand J Gastroenterol. 2023. PMID: 36799202
BACKGROUND: Studies on aspirin's effects on metabolic-associated fatty liver disease (MAFLD) are limited. The aim of this study was to assess the association between aspirin and all-cause and cardiovascular disease (CVD) mortality in individuals with MAFLD. . …
BACKGROUND: Studies on aspirin's effects on metabolic-associated fatty liver disease (MAFLD) are limited. The aim of this stud …
Aspirine ou clopidogrel ? Le débat continue.
Abellan C. Abellan C. Rev Med Suisse. 2023 Apr 12;19(822):739. doi: 10.53738/REVMED.2023.19.822.739. Rev Med Suisse. 2023. PMID: 37057858 French. No abstract available.
79,562 results
You have reached the last available page of results. Please see the User Guide for more information.